CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

CHAMPIONS ONCOLOGY, INC.

CSBR
$73MMicro Cap

Next catalyst

No upcoming catalyst in our data

No upcoming FDA decision, filing or trial readout is on file for CSBR. That does not mean none is planned.

Get an email about CSBR's next catalysts

Track CHAMPIONS ONCOLOGY (CSBR) and we email you when an FDA date moves, 7 days and 1 day before the decision when the exact day is known, and when it is announced. Free account, no card.

1 upcoming event in our data (earnings).See the timeline

Catalyst Timeline

1 upcoming, 0 past

Earnings

CSBR Earnings Report

December 2026~

Date estimated from past reporting pattern, not yet confirmed by the company | FQ end Oct/2026 | Call: tbd

Market Overview

Stock performance and key metrics

NASDAQBiological Products, (No Diagnostic Substances)πŸ‡ΊπŸ‡ΈNorth AmericaBALTIMORE213 employees

Champions Oncology is an American technology company that develops mouse avatars. Called TumorGrafts, they are used to test a panel of chemotherapy regimens, targeted therapies and monoclonal antibodies to identify potential therapeutic options for cancer patients. The company was founded in 2007 by David Sidransky, M.D., a Johns Hopkins University oncologist.

Drug Pipeline

No drugs found in this phase.

Frequently asked questions

When is CHAMPIONS ONCOLOGY, INC.'s next FDA catalyst?β†’

CatalystAlert tracks every upcoming catalyst for CHAMPIONS ONCOLOGY, INC. (CSBR) β€” PDUFA decision dates, Phase 1/2/3 trial readouts, FDA advisory committee meetings and NDA/BLA filings β€” each confidence-rated as confirmed, estimated or AI-detected.

How do I track CSBR biotech catalysts?β†’

Add CSBR to your CatalystAlert watchlist for alerts ahead of each catalyst, and follow CHAMPIONS ONCOLOGY, INC.'s live catalyst calendar, drug pipeline and clinical-trial timeline on this page β€” sourced from ClinicalTrials.gov, FDA and SEC filings.

Data is aggregated from public sources (FDA, SEC, ClinicalTrials.gov). While we strive for accuracy, information may be incomplete, delayed, or contain errors. Terms apply